105 related articles for article (PubMed ID: 9112427)
1. HLA and graft-versus-host disease: a population-based study of HLA phenotypes of Jewish and Arabic bone marrow transplanted patients in Israel.
Bishara A; Brautbar C; Nagler A
Leuk Res; 1997 Feb; 21(2):111-8. PubMed ID: 9112427
[TBL] [Abstract][Full Text] [Related]
2. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
3. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
[TBL] [Abstract][Full Text] [Related]
4. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
Cohen R; Metzger S; Nahir M; Chajek-Shaul T
Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
6. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
Weston LE; Geczy AF; Farrell C
Transplantation; 1997 Sep; 64(6):836-41. PubMed ID: 9326407
[TBL] [Abstract][Full Text] [Related]
7. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
8. What determines who develops graft-versus-host disease: the graft or the host (or both)?
Gale RP; Horowitz MM; Butturini A; Barrett AJ; Kolb HJ
Bone Marrow Transplant; 1992 Aug; 10(2):99-102. PubMed ID: 1525613
[TBL] [Abstract][Full Text] [Related]
9. The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings.
Roosnek E; Hogendijk S; Zawadynski S; Speiser D; Tiercy JM; Helg C; Chapuis B; Gratwohl A; Gmür J; Seger R
Transplantation; 1993 Sep; 56(3):691-6. PubMed ID: 8212168
[TBL] [Abstract][Full Text] [Related]
10. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
[TBL] [Abstract][Full Text] [Related]
11. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
Speiser DE; Löliger CC; Siren MK; Jeannet M
Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
[TBL] [Abstract][Full Text] [Related]
13. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.
DeGast GC; Mickelson EM; Beatty PG; Amos D; Sullivan KM; Schoch HG; Thomas ED; Hansen JA
Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333
[TBL] [Abstract][Full Text] [Related]
14. Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab.
Perz JB; Szydlo R; Sergeant R; Sanz J; O'Shea D; Khan T; Davey N; Loaiza S; Davis J; Apperley JF; Olavarria E
Transpl Immunol; 2007 Nov; 18(2):179-85. PubMed ID: 18005865
[TBL] [Abstract][Full Text] [Related]
15. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
16. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
Reiter O; Ben Amitai D; Amitay-Laish I; Israeli M; Pavlovsky L; Hodak E
Arch Dermatol Res; 2017 Dec; 309(10):851-856. PubMed ID: 28948342
[TBL] [Abstract][Full Text] [Related]
17. New strategies for selection of unrelated bone marrow donors.
Martinelli G; Buzzi M; Farabegoli P; Testoni N; Mantovani V; Calori E; Rosti G; Bandini G; Bragliani M; Panzica G
Bone Marrow Transplant; 1993; 11 Suppl 1():31-2. PubMed ID: 8448542
[TBL] [Abstract][Full Text] [Related]
18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
19. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
[TBL] [Abstract][Full Text] [Related]
20. HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling.
Martin PJ; Gooley T; Anasetti C; Petersdorf EW; Hansen JA
Biol Blood Marrow Transplant; 1998; 4(3):128-33. PubMed ID: 9923410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
